Urea derivatives as integrin alpha 4 antagonists

Details for Australian Patent Application No. 2002228048 (hide)

Owner Laboratorios Almirall, S.A.

Inventors Bach Tana, Jordi; Navarro Romero, Eloisa; Jimenez Mayorga, Juan Miguel; Ontoria Ontoria, Jesus Maria

Agent Davies Collison Cave

Pub. Number AU-B-2002228048

PCT Pub. Number WO2002/057242

Priority 200100126 19.01.01 ES

Filing date 15 January 2002

Wipo publication date 30 July 2002

Acceptance publication date 13 March 2008

International Classifications

C07D 295/18 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/198 (2006.01)

A61K 31/223 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4375 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61K 31/4545 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/02 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/04 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/28 Drugs for disorders of the nervous system

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-B-2002228048

17 May 2007 Change of Name(s) of Applicant(s), Section 104

  Almirall Prodesfarma, S.A. The name of the applicant has been changed to Laboratorios Almirall, S.A.

13 March 2008 Application Accepted

  Published as AU-B-2002228048

10 July 2008 Standard Patent Sealed

11 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002228049-METHOD FOR PRODUCING MONOCOMPONENT-MICROFILAMENTS AND OBTAINING A NONWOVEN, WOVEN OR KNIT FABRIC COMPRISED OF THESE MICROFILAMENTS

2002228047-Use of type 4 phosphodiesterase inhibitors in myocardial diseases